XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net loss $ (6,747) $ (7,861)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock option compensation expense 2,148 25
Restricted stock compensation expense   30
Depreciation expense 39 48
Amortization of right of use assets   11
Warrant liability fair value adjustment   2,832
Non-cash interest income (1) (3)
Interest expense accrued related to convertible notes 39 40
Changes in assets and liabilities:    
(Increase) decrease in prepaid expenses and other assets 302 (880)
Increase in accounts receivable (18) (48)
Increase in inventories (254) (136)
Increase in accounts payable and accrued expenses 164 901
Decrease in deferred revenue (239) (188)
Net cash used in operating activities (4,567) (5,229)
Cash flows from investing activities:    
Purchase of property, plant and equipment (9) (180)
Net cash used in investing activities (9) (180)
Cash flows from financing activities:    
Principal payments on financing leases   (11)
Net payments related to registration costs   (106)
Net proceeds from the exercise of warrants 2,376  
Net cash provided by/(used in) financing activities 2,376 (117)
Foreign currency effects on cash 94 64
Net decrease in total cash (2,106) (5,462)
Total Cash:    
Beginning of period 28,756 10,183
End of period 26,650 4,721
Supplemental Disclosure of Cash Flow Information:    
Interest expense 3 4
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Reclassification of 2019 warrants from liability to equity   $ 6,199
Board of Directors Chairman    
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Issuance of restricted stock for accrued fees due to a former board member $ 57